Nuedexta Clinical Trials

The Clinical Trails of Nuedexta Medication

Handsome young doctor holding clipboard and analyzing the results of clinical trials with elderly patient. Isolated on white background.

Nuedexta is a drug which is being used to treat people who are suffering from a condition known as Pseudobulbar affect. Nuedexta is still quite a young, and untested drug, and there are a series of clinical trials being performed at the moment to determine the effectiveness and safety of the drug.

The Nuedexta clinical trials have, so far, been quite positive and promising. It should not be long before the drug is prescribed commonly to treat people with PBA. There are always safety concerns with new medications, and the outcomes of the clinical trials so far are being watched quite closely.

Nuedexta Has Been Licensed for Marketing in Some Parts of the World

Neudexta was given a marketing license in 2013 by the EMA. The license was withdrawn for EU marketing in 2016 and did not get licensed at all for marketing in the UK. For it to be licensed, it will need far more testing than it has had so far. The drug is still available in the USA.

Effects of Nuedexta Studied in Clinical Trials

One of the most recent Nuedexta clinical trials focused on the effects of the drug on nursing home patients who suffered from PBA. The experiment spanned six months and looked at a total of 125 patients across several states. Unfortunately, evidence from this study was inconclusive because there was difficulty recruiting patients, so the study was terminated before the six month period was up.

Another study looked at the safety and tolerability of Nuedexta for managing PBR in people who had suffered from a range of conditions, including traumatic brain injury and dementia, as well as strokes. This study spanned 12 weeks and used a 20mg dose of Nuedexta. The study engaged 367 participants and showed promising results across several outcome measures relating to emotional episodes and other difficulties.

Nuedexta is Often Mis-Prescribed

red pills or capsules in blue background

Clinical trials have been promising when Nuedexta has been tested for PBA alone. However, there are some concerns about the safety of the drug and the way that it is prescribed. Recent research and studies into the prescription of the medication indicate that doctors often prescribe it to people who have dementia, Parkinson’s, or another underlying condition. This is concerning because the drug has not been tested for use in this way. It is uncertain whether there may be interactions between Nuedexta and other drugs, or whether it may have unexpected impacts on people who are suffering from other conditions. This is something that the medical community is calling for further research.

Technically, prescribing Neudexta for PBA that is associated with other underlying conditions is off-label. This is something that a lot of doctors and consultants overlook, but it should be a matter of significant concern given the potential for the drug to have unwanted side-effects.

Indeed, Medicare has asked that insurance companies monitor the prescription of Nuedexta. That’s because it is being marketed aggressively for dementia patients. Though, it has not been properly tested and trialed for that kind of use. It is also being marketed for Alzheimer’s. Other drugs are likely to be far better suited for managing the symptoms that people living with Alzheimer’s are experiencing. People who use Nuedexta for Alzheimer’s are more likely to experience falls, and other secondary issues, including UTIs, than those who are given more appropriate drugs.

One challenge that doctors face is that there are not many options for managing the behavioral issues associated with Alzheimer’s and dementia. It can be tempting to use something like Nuedexta, which may help with those issues in the short term. Unfortunately, Nuedexta is just a band-aid for such problems, and it is not going to manage the condition itself. In the vast majority of cases, it would be better for doctors to find ways to proactively slow the progress of Alzheimer’s or to find ways for the patient to cope with dementia without using an off-label drug that has not been tested for that kind of application. Doctors and nursing home workers are encouraged to avoid this kind of excessive over-prescription until more data is clarifying the safety of the drug.

What We’ve Learned From Nuedexta Clinical Trials

Findings Clinical Trials with Nuedexta

clinical research trialNuedexta has been tested extensively, before and after its release. We’ve been able to glean a lot of information from these clinical trials. Today, we know far more about Nuedexta than we once did.
What Kinds Of Results Have We Seen?
A lot of these trials have led to extremely positive results. Some of the most promising results involved using Nuedexta to treat people that have ALS. Studies have found that the drug can ease many ALS symptoms, including speech difficulties and issues with swallowing.
While a lot of these tests have been small in scale, the majority of the patients responded very positively to this drug. These studies have been extremely promising. New studies are being launched so that we can glean more information about the effectiveness of this medication.




The Goal Of These Studies

The primary goal of the research and studies involving Nuedexta is to find ways to treat ALS. Researchers are looking for ways to improve the quality of life for people with ALS. Medications like this are a big part of it.
Of course, not all of the clinical trials involving Nuedexta have been about ALS and ALS symptoms. There have also been studies that used Nuedexta to treat patients with Alzheimer’s Disease. People with Alzheimer’s often experience neurological problems. For example, people might have unexplained bouts of crying or laughter. Early research has shown that
Nuedexta can treat this effectively as well.
Nuedexta has even been tested on adults with autism. It seems clear that this medication can effectively treat all kinds of people with neurological disorders.
What’s Next?
What’s next for Nuedexta? While the medication has been approved by the FDA and is being prescribed now, experts still want to learn more about it. There will continue to be clinical trials involved Nuedexta in the future.
It is unlikely that this medication will be changed in any major way. However, it is possible that the drug will be prescribed to a larger number of people. Because trials have shown that it can treat a range of issues effectively, it seems likely that a growing number of doctors are going to be prescribing this drug to their patients.
At this current point in time, it seems unlikely that doctors will be prescribing Nuedexta to children. It is challenging to confirm that a medication like this is safe for children to take.
However, it is likely that this drug is going to be given to a growing number of people. As doctors learn more about this drug and what it is capable of, they will be far more likely to recommend it to their patients in the future.




Nuedexta clinical trials have provided us with a lot of valuable insight. Thanks to these tests, doctors will be able to prescribe Nuedexta to people that will benefit from it greatly. Hopefully, experts will continue to test Nuedexta and learn more about it. There are still many things that we need to learn.